Thrombotic Thrombocytopenic Purpura and Anti-Thrombotic Therapy Targeted to Von Willebrand Factor

By  

Current Vascular Pharmacology, Vol. 10, Iss. 6, 2012-11 ,pp. : 762-766

Bentham Science Publishers

Access to resources Recommend Favorite

Two Novel Anti-von Willebrand Factor Monoclonal Antibodies - implications for intimal neovascularization and hemorrhage

By Spadafora-Ferreira M.   Lopes A.A.B.   Coelho V.   Guilherme L.   Kalil J.  

Thrombosis Research, Vol. 97, Iss. 2, 2000-01 ,pp. : 3-13

Elsevier

Access to resources Recommend Favorite

Domain Specific Monoclonal Anti-factor VIII Antibodies Generated by Inclusion Body-renatured Factor VIII Peptides

By Huang C.-C.   Li L.-T.   Shen M.-C.   Chen  

Thrombosis Research, Vol. 101, Iss. 5, 2001-03 ,pp. : 405-415

Elsevier

Access to resources Recommend Favorite

EFFECT OF MULTIMERIZATION OF HUMAN AND RECOMBINANT VON WILLEBRAND FACTOR ON PLATELET AGGREGATION, BINDING TO COLLAGEN AND BINDING OF COAGULATION FACTOR VIII

By Fischer B.E.   Kramer G.   Mitterer A.   Grillberger L.   Reiter M.   Mundt W.   Dorner F.   Eibl J.  

Thrombosis Research, Vol. 84, Iss. 1, 1996-10 ,pp. : 55-66

Elsevier

Access to resources Recommend Favorite

Impact of Factor VIII and von Willebrand Factor Plasma Levels on Cerebral Venous and Sinus Thrombosis: Are They Independent Risk Factors?

By  

European Neurology, Vol. 66, Iss. 4, 2011-09 ,pp. : 243-246

Karger

Access to resources Recommend Favorite